Sniper Spotlight with Ricardo Capone from Dr. Green Cannabis
Sep 9, 2024
For the last five years, we’ve been involved heavily in the medical cannabis space in Portugal. We have facilities where we grow medical cannabis for distribution to institutions that utilize it. Conditions like multiple sclerosis, epilepsy, and Parkinson’s disease — these issues can be treated with cannabis because the problem is usually in the endocannabinoid system in the human body.
So, we develop different technologies, and our primary focus has been biotechnology. If we have a patient, we’ll take a swab of their mouth and analyze the DNA structure of the person, and we can see where the breakdown is that’s causing them to have a problem.
We take that information through to our second department, plant genomics. We have a strain library with around 2,100 strains analyzed across 50,000 seeds, and what it tells us is the nuclear genetics and the mitochondrial genetics of the plant. These two genetic bases give you a blueprint for where the plant will be as an adult. We can take those genetics as a seed and build a digital map of where that cannabis plant is going to be in terms of its THC, CBD, CBG, CBA contents, and all the different components that are beneficial for human needs.
We take that information, digitize it, and we have the human DNA profile. Then we cross-reference those two profiles with an algorithm I wrote that cross-references both databases and gives us an output of which constituent parts of which plant would best treat the patient.
Now, it may tell us that three plants would be needed. And traditionally, you would want to crossbreed those strains into one medicine for the patient. But crossbreeding takes a long time. You could be looking at four years to take three plants and crossbreed them. Obviously, if you’ve got a headache today, you don’t want to wait four years for a paracetamol. So, we needed to shorten that down, and that’s what we did. Parts of our intellectual property lies in a method that we use to basically cross those strains.